Freelance science writer and frequent Cancer Network and OncoTherapy Network contributor.
Follow Her on Twitter
Protecting Ovary Function During Breast Cancer Chemotherapy
The risk of early, sudden-onset menopause in women treated for early-stage breast cancer can be reduced with goserelin, a gonadotropin-releasing hormone agonist.
Does Coffee Lower the Risk of Endometrial Cancer?
Drinking coffee multiple times a day may decrease the risk of endometrial cancer in women, according to a new study.
Birth Control Pill Linked to Increased Glioma Risk
A history of hormonal contraceptive use in younger women for 5 years or more was found to be associated with a possible increased risk of glioma.
Metabolic Syndrome Linked to Higher Endometrial Cancer Risk
Women with metabolic syndrome who are age 65 or older have an increased risk of endometrial cancer, according to the results of a new study.
New HPV Vaccine Could Prevent 90% of Cervical Cancers
A new human papillomavirus (HPV) vaccine that protects against nine types of HPV and would protect against about 90% of cervical cancers could be available in 2015.
Maintenance Pazopanib in Ovarian Cancer: No Survival Benefit, High AEs
Maintenance therapy with pazopanib improved progression-free survival by 5.6 months in advanced ovarian cancer patients, according to results of a new study.
Baldness in Middle Age May Be Linked to Aggressive Prostate Cancer
A large trial found that men with moderate baldness at age 45 had an increased risk of developing aggressive prostate cancer compared with men with no baldness.
Hysterectomy Technique May Spread Uterine Cancer
Researchers found that uterine cancers were present in 27 per 10,000 women undergoing morcellation, which fragments the uterus and can spread cancer cells.
For Some, Aspirin Cuts Colon Cancer Risk in Half
A new study shows that people with high levels of the 15-PGDH enzyme who used aspirin regularly were half as likely to be diagnosed with colorectal cancer.
Immunotherapy Combination Approaches
At the 1-day Cancer Immunotherapy: A Long Awaited Reality Conference, representatives from biotechnology companies and research clinicians working on immunotherapies discussed the promise of combination immunotherapies in cancer.
By clicking Accept, you agree to become a member of the UBM Medica Community.